Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
5.57
-0.06 (-1.07%)
Jun 8, 2026, 4:00 PM EDT - Market closed
Lifecore Biomedical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | May '25 May 25, 2025 | May '24 May 26, 2024 | May '23 May 28, 2023 | May '22 May 29, 2022 | May '21 May 30, 2021 |
| 126.49 | 128.87 | 128.26 | 103.27 | 111.27 | 100.87 | |
Revenue Growth (YoY) | -2.93% | 0.47% | 24.20% | -7.19% | 10.31% | -36.98% |
Cost of Revenue | 87.5 | 88.57 | 86.41 | 75.28 | 72.2 | 61.94 |
Gross Profit | 39 | 40.3 | 41.85 | 27.99 | 39.07 | 38.94 |
Selling, General & Admin | 33.33 | 44.05 | 40.46 | 38.97 | 34.66 | 27.72 |
Research & Development | 7.58 | 8.26 | 8.58 | 8.74 | 7.84 | 6.68 |
Other Operating Expenses | -2.43 | 5.24 | 1.66 | 2.08 | 8.36 | 13.36 |
Total Operating Expenses | 38.49 | 57.54 | 50.69 | 49.78 | 50.86 | 47.76 |
Operating Income | 5.84 | -17.25 | -8.84 | -21.8 | -11.79 | -8.82 |
Interest Income | 0.3 | - | - | - | - | 0.05 |
Interest Expense | -26.43 | -21.84 | -18.09 | -17.58 | -15.47 | -8.93 |
Other Non-Operating Income (Expense) | -5.19 | 0.41 | 36.45 | -24.55 | 6.57 | -12.08 |
Total Non-Operating Income (Expense) | -31.32 | -21.43 | 18.36 | -42.13 | -8.9 | -20.96 |
Pretax Income | -30.81 | -38.67 | 9.51 | -63.93 | -20.69 | -29.79 |
Provision for Income Taxes | -0.41 | -0.04 | -0.18 | -0.31 | 5.21 | 6.35 |
Net Income | -1.15 | -38.72 | 9.33 | -64.24 | -15.48 | -23.44 |
Net Income Attributable to Preferred Dividends | 3.72 | 5.64 | - | - | - | - |
Earnings From Discontinued Operations | - | - | 2.68 | -35.33 | -101.93 | - |
Net Income to Common | -34.94 | -44.36 | 12.01 | -99.56 | -117.41 | -23.44 |
Shares Outstanding (Basic) | 37 | 35 | 30 | 30 | 29 | 29 |
Shares Outstanding (Diluted) | 37 | 35 | 37 | 30 | 29 | 29 |
Shares Change (YoY) | 7.29% | -5.02% | 22.36% | 1.67% | 0.59% | 0.45% |
EPS (Basic) | -0.94 | -1.27 | 0.39 | -3.32 | -3.97 | -1.10 |
EPS (Diluted) | -0.94 | -1.27 | 0.33 | -3.32 | -3.97 | -1.10 |
Free Cash Flow | 6.35 | -13.62 | -18.14 | -38.92 | -52.53 | -8.75 |
Free Cash Flow Per Share | 0.17 | -0.39 | -0.49 | -1.30 | -1.78 | -0.30 |
Gross Margin | 30.83% | 31.27% | 32.63% | 27.10% | 35.11% | 38.60% |
Operating Margin | 4.62% | -13.38% | -6.90% | -21.11% | -10.60% | -8.75% |
Profit Margin | -0.91% | -30.04% | 7.28% | -62.20% | -13.91% | -23.23% |
FCF Margin | 5.02% | -10.57% | -14.14% | -37.69% | -47.21% | -8.68% |
EBITDA | 14.04 | -9.22 | -0.89 | -8.62 | 6.27 | 11.04 |
EBITDA Margin | 11.10% | -7.15% | -0.69% | -8.35% | 5.63% | 10.95% |
EBIT | 5.84 | -17.25 | -8.84 | -21.8 | -11.79 | -8.82 |
EBIT Margin | 4.62% | -13.38% | -6.90% | -21.11% | -10.60% | -8.75% |
Effective Tax Rate | 1.34% | 0.11% | -1.92% | 0.48% | -25.19% | -21.32% |